Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

Whether you want passive income or not, dividend-paying stocks tend to outperform their non-dividend-paying cousins.

Celltrion's asthma treatment Omlyclo, a biosimilar of Novartis's Xolair, has received Canadian approval for chronic urticaria, rhinosinusitis, and allergic asthma ...

A new study published in the Ear, Nose and Throat Journal found that the severity of chronic rhinosinusitis with nasal ...

Group 2 Innate lymphoid cells (ILC2) are a source of type 2 cytokines, such as interleukin-5 (IL-5). Here Troch, Jakob et al. show a non-redundant role of ILC2-derived IL-5 required for the ...

IT’S that time of year where we’re greeted by a cacophony of coughs, sneezes and sniffles wherever we go. You might think a cough is a cough, but different conditions will produce a ...

Dr. Sean McWilliams brings two decades of specialized ear, nose and throat expertise to Mid Bay ENT, offering expanded ...

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

Comorbid asthma, nonsmoking status, and the ethmoid/maxillary sinus ratio were significant predictors of eosinophilic CRSwNP.

Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.

Priyanka Chopra opened up about a cosmetic procedure she deeply regrets. During an interview on Howard Stern’s radio show, ...